Literature DB >> 1855586

Regulation of protein synthesis at the elongation stage. New insights into the control of gene expression in eukaryotes.

A G Ryazanov1, B B Rudkin, A S Spirin.   

Abstract

There are many reports which demonstrate that the rate of protein biosynthesis at the elongation stage is actively regulated in eukaryotic cells. Possible physiological roles for this type of regulation are: the coordination of translation of mRNA with different initiation rate constants; regulation of transition between different physiological states of a cell, such as transition between stages of the cell cycle; and in general, any situation where the maintenance of a particular physiological state is dependent on continuous protein synthesis. A number of covalent modifications of elongation factors offer potential mechanisms for such regulation. Among the various modifications of elongation factors, phosphorylation of eEF-2 by the specific Ca2+calmodulin-dependent eEF-2 kinase is the best studied and perhaps the most important mechanism of regulation of elongation rate. Since this phosphorylation is strictly Ca(2+)-dependent, and makes eEF-2 inactive in translation, this mechanism could explain how changes in the intracellular free Ca2+ concentration may regulate elongation rate. We also discuss some recent findings concerning elongation factors, such as the discovery of developmental stage-specific elongation factors and the regulated binding of eEF-1 alpha to cytoskeletal elements. Together, these observations underline the importance of the elongation stage of translation in the regulation of the cellular processes essential for normal cell life.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855586     DOI: 10.1016/0014-5793(91)80798-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  26 in total

Review 1.  Subcellular localization of mRNA in neuronal cells. Contributions of high-resolution in situ hybridization techniques.

Authors:  M E Martone; J A Pollock; M H Ellisman
Journal:  Mol Neurobiol       Date:  1998-12       Impact factor: 5.590

2.  Expression of elongation factor-2 kinase contributes to anoikis resistance and invasion of human glioma cells.

Authors:  Li Zhang; Yi Zhang; Xiao-yuan Liu; Zheng-hong Qin; Jin-ming Yang
Journal:  Acta Pharmacol Sin       Date:  2011-01-31       Impact factor: 6.150

Review 3.  Mechanism and regulation of eukaryotic protein synthesis.

Authors:  W C Merrick
Journal:  Microbiol Rev       Date:  1992-06

4.  Intracellular complexes of the beta2 subunit of the nicotinic acetylcholine receptor in brain identified by proteomics.

Authors:  Nadine Kabbani; Matthew P Woll; Robert Levenson; Jon M Lindstrom; Jean-Pierre Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-10       Impact factor: 11.205

5.  Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway.

Authors:  N T Redpath; E J Foulstone; C G Proud
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

6.  Ultrastructural localization of dendritic messenger RNA in adult rat hippocampus.

Authors:  M E Martone; J A Pollock; Y Z Jones; M H Ellisman
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

Review 7.  Translation-targeted therapeutics for viral diseases.

Authors:  J B Harford
Journal:  Gene Expr       Date:  1995

8.  Proteomic profiling of human placenta-derived mesenchymal stem cells upon transforming LIM mineralization protein-1 stimulation.

Authors:  Zhen Zhu; Zhihui Liu; Jingyue Liu; Ming Bi; Taoyuan Yang; Jingyun Wang
Journal:  Cytotechnology       Date:  2014-01-28       Impact factor: 2.058

9.  Mechanisms mediating the effects of alcohol and HIV anti-retroviral agents on mTORC1, mTORC2 and protein synthesis in myocytes.

Authors:  Ly Q Hong-Brown; Abid A Kazi; Charles H Lang
Journal:  World J Biol Chem       Date:  2012-06-26

Review 10.  The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.

Authors:  Lisa M Monteggia; Erinn Gideons; Ege T Kavalali
Journal:  Biol Psychiatry       Date:  2012-10-11       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.